# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-103931
Filing Date
2025-04-29
Accepted
2025-04-29 16:35:16
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | d903354ddefa14a.htm | DEFA14A | 10641
2 | GRAPHIC | g903354g03a01.jpg | GRAPHIC | 400399
3 | GRAPHIC | g903354g04x01.jpg | GRAPHIC | 267258
| Complete submission text file | 0001193125-25-103931.txt |  | 930582

Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

EIN.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38683 | Film No.: 25888381
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)